Legal & General Group
AQST icon

Legal & General Group’s Aquestive Therapeutics AQST Stock Holding History

Legal & General Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.6K Buy
10,492
+1,152
+12% +$4.85K ﹤0.01% 2812
2026
Q1 		$38.8K Sell
9,340
-72,555
-89% -$294K ﹤0.01% 2739
2025
Q4 		$529K Buy
81,895
+73,584
+885% +$459K ﹤0.01% 2411
2025
Q3 		$46.5K Hold
8,311
– – ﹤0.01% 2750
2025
Q2 		$27.5K Buy
8,311
+1,421
+21% +$4.08K ﹤0.01% 2883
2025
Q1 		$20K Hold
6,890
– – ﹤0.01% 2941
2024
Q4 		$24.5K Hold
6,890
– – ﹤0.01% 2958
2024
Q3 		$34.3K Hold
6,890
– – ﹤0.01% 2859
2024
Q2 		$17.8K Buy
+6,890
New +$23K ﹤0.01% 3069
2021
Q2 		– Sell
-2,211
Closed -$11K – 3485
2021
Q1 		$11K Sell
2,211
-282
-11% -$1.5K ﹤0.01% 3342
2020
Q4 		$13K Hold
2,493
– – ﹤0.01% 3234
2020
Q3 		$12K Sell
2,493
-760
-23% -$4.97K ﹤0.01% 3144
2020
Q2 		$16K Buy
+3,253
New +$15K ﹤0.01% 3148
2019
Q3 		– Sell
-2,050
Closed -$9K – 3351
2019
Q2 		$9K Hold
2,050
– – ﹤0.01% 3371
2019
Q1 		$14K Buy
2,050
+1,240
+153% +$8.69K ﹤0.01% 3186
2018
Q4 		$5K Hold
810
– – ﹤0.01% 3333
2018
Q3 		$14K Buy
+810
New +$13.4K ﹤0.01% 3276

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Legal & General Group's AQST Position: Q2 2026 in Review

Legal & General Group increased its Aquestive Therapeutics (AQST) stake by 12% in Q2 2026, buying an estimated $4.85K and bringing the position to 10,492 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2812.

Legal & General Group first reported a position in AQST in Q3 2018 and has held it in 17 quarters since. The position peaked at $529K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Legal & General Group held 10,492 shares of Aquestive Therapeutics worth $43.6K as of Q2 2026.
  • Legal & General Group bought 1,152 Aquestive Therapeutics shares in Q2 2026, an estimated $4.85K.
  • Aquestive Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2812 holding.
  • Legal & General Group first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 17 quarters since.
  • Legal & General Group's Aquestive Therapeutics position peaked at $529K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.